http://web.archive.org/web/20130921094928id_/http://www.cnn.com/2010/HEALTH/11/19/fda.removes.drug/

@entity0 -- the pharmaceutical company that makes the prescription pain medications @entity6 and @entity6 has agreed to withdraw the drugs from the @entity9 market at the request of the @entity2 , the @entity2 said friday			1
the @entity2 says the drug , propoxyphene , puts patients at risk of potentially serious or fatal heart rhythm abnormalities			1
since 2009 , 10 million people have been prescribed some form of the drug			0
" we recommend to physicians stop prescribing the drugs			0
as for patients , do not stop taking it , but we urge you to contact your health care professional			0
do not delay , " said @entity25 , director of the @entity2 's @entity26			2
@entity27 manufactures @entity6 and @entity6 , two brand name versions of propoxyphene			1
the @entity2 also asked generic makers of the pain medicine to voluntarily remove their products			2
the decision to remove the drug came after the @entity2 reviewed a new trial study that looked at the drug 's impact on heart rhythms			1
" the drug 's effectiveness in reducing pain is no longer enough to outweigh the drug 's serious potential heart risks , " the @entity2 said in a statement released friday			2
@entity6 , first approved by the @entity2 in 1957 , is an opioid used to treat mild to moderate pain			1
it is sold under various names both alone , such as @entity6 , or in combination with acetaminophen , such as @entity6			0
since 1978 , the @entity2 has received two requests to remove propoxyphene from the market , but concluded that the benefits of propoxyphene for pain relief at recommended doses outweighed the safety risks			0
@entity1 's @entity59 contributed to this report .			0

@entity6 , @entity6 brands pulled along with generics
@entity2 *concerned* about heart rhythms
generic versions a concern , too

@entity2:FDA
@entity1:CNN
@entity0:Washington
@entity26:Office of Surveillance and Epidemiology
@entity6:Darvocet
@entity25:Gerald Dal Pan
@entity9:U.S.
@entity59:Val Willingham
@entity27:Xanodyne Pharmaceuticals Inc.